Anticipated $1.41 EPS for IQVIA Holdings Inc. (IQV) as of May, 1

IQVIA Holdings Inc. (NYSE:IQV)’s quarterly earnings will be published on May, 1., according to Zacks. The earnings per share diference is $0.17 or 13.71 % up from last years number. Previous year: $1.24; Analysts forcast: $1.41. If reported the P/E will be 25.27 with $277.20M profit. After $1.37 EPS report previous quarter, Wall Street now forecasts 2.92 % EPS growth of IQVIA Holdings Inc.. The stock decreased 0.46% or $0.66 during the last trading session, hitting $142.52.Currently IQVIA Holdings Inc. is uptrending after 45.57% change in last April 14, 2018. IQV has also 814,317 shares volume. IQV outperformed by 41.20% the S&P 500.

IQVIA Holdings Inc. (NYSE:IQV) Ratings Coverage

In total 3 analysts cover IQVIA Holdings (NYSE:IQV). “Buy” rating has 3, “Sell” are 0, while 0 are “Hold”. 100% are bullish. 3 are the (NYSE:IQV)’s analyst reports since February 19, 2019 according to StockzIntelligence Inc. In Tuesday, February 19 report Wells Fargo maintained it with “Outperform” rating and $160 target. The stock rating was maintained by Argus Research with “Buy” on Monday, February 25. In Monday, March 18 report Barclays Capital maintained the stock with “Overweight” rating.

IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific.The firm is worth $28.02 billion. It operates through three divisions: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.The P/E ratio is 114.94. The Commercial Solutions segment offers country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations.

For more IQVIA Holdings Inc. (NYSE:IQV) news brought out recently go to: 247Wallst.com, Seekingalpha.com, Seekingalpha.com, Pehub.com or Benzinga.com. The titles are as follows: “Morgan Stanley Picks 30 Stocks for 2021 – 24/7 Wall St.” brought out on March 15, 2019, “Bigger Is Not Always Better – Seeking Alpha” on May 22, 2018, “IQVIA Q4 2018 Earnings Preview – Seeking Alpha” with a publish date: February 13, 2019, “PE-backed Gemini adds ex-3i chairman and managing partner to board – PE Hub” and the last “BofA Upgrades Iqvia (NYSE:IQV) On Upside Potential – Benzinga” with publication date: July 27, 2018.

IQVIA Holdings Inc. (NYSE:IQV) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.